title: A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology.
abstract: Familial hypercholesterolaemia (FH) is the most common monogenic cause of premature coronary artery disease. FH remains underdiagnosed and inadequately treated, with no national strategies for dealing with the problem. We report an executive summary of a comprehensive model of care for FH developed in Western Australia.
authors.affiliation: Lipid Disorders Clinic, Department of Internal Medicine, Royal Perth Hospital, WA 6847, Australia. gerald.watts@uwa.edu.au
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Watts
authors.forename: Frank M
authors.initials: FM
authors.lastname: van Bockxmeer
authors.forename: Timothy
authors.initials: T
authors.lastname: Bates
authors.forename: John R
authors.initials: JR
authors.lastname: Burnett
authors.forename: Amanda
authors.initials: A
authors.lastname: Juniper
authors.forename: Peter
authors.initials: P
authors.lastname: O'Leary
mesh_terms: D000293:Adolescent; D000328:Adult; D000465:Algorithms; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002648:Child; D019091:Critical Pathways; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D018579:Patient Selection; D011314:Preventive Health Services; D040242:Risk Reduction Behavior; D014904:Western Australia; D055815:Young Adult
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors